The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis

Multiple Sclerosis

Volumn 13, Issue 4, 2007, Pages 527-533

  Miller, Linda ^a   Mattison, P ^a   Paul, L ^b   Wood, L ^b  

^a Ayrshire Central Hospital   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Multiple sclerosis; Muscle spasm; Pain; Spasticity; Transcutaneous electrical nerve stimulation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FREQUENCY MODULATION; HUMAN; MALE; MULTIPLE SCLEROSIS; MUSCLE SPASM; OUTCOMES RESEARCH; PAIN; PAIN ASSESSMENT; QUADRICEPS FEMORIS MUSCLE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SPASTICITY; STATISTICAL SIGNIFICANCE; TIME; TRANSCUTANEOUS NERVE STIMULATION; VISUAL ANALOG SCALE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; PATIENT SATISFACTION; QUESTIONNAIRES; REFLEX; TENDONS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME;

EID: 34249324854     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506071509     Document Type: Article

References (38)

1. Paty DW, Ehers GC. Multiple sclerosis. FA Davis Co, 1998.
2. MS Society. Symptom management survey. The MS Society, 1998.
3. Shakespeare D, Boggild M, Young C. Anti-spasticity agents for multiple sclerosis. The Cochrane Library 2001, Issue 3.
4. Davidoff R. Antispasticity drugs: mechanisms of action. Am I Neurol 1985; 17: 107-16.
5. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity Part II: general and regional treatments. Muscle Nerve 1997; Suppl 6: 92-120.
6. Satkunam. L. Rehabilitation medicine. 3: Management of adult spasticity. Can Med Assoc J 2003; 169: 1173-79.
7. Wallace J. Summary of combined clinical analysing controlled clinical trials with Tizanadine. Neurology 1994; 44: 60-69.
8. Walsh D. TENS: clinical applications and related theory. Churchill Livingstone, 1997.
9. Alfieri V. Electrical treatment of spasticity. Scand J Rehabil Med 1982; 14: 177-82.
10. Bajd T, Gregoric M, Vodovnik L, Benko H. Electrical stimulation in treating spasticity resulting from spinal cord injury. Arch Phys Med Rehabil 1985; 66: 515-17.
11. Chan C, Tsang H. Inhibition of the human flexion reflex by low intensity, high frequency transcutaneous electrical nerve stimulation (TENS) has a gradual onset and offset. Pain 1987; 28: 239-53.
12. Levin MF, Chan CWY. Relief of hemiparetic spasticity by TENS is associated with improvement in reflex and voluntary motor functions. Electroencephal Clin Neurophysiol 1992; 85: 131-42.
13. Dewald J, Given JD, Yamada D, Rymer W. Significant reductions in upper limb spasticity in hemiparetic stroke subjects using cutaneous levels of electrical stimulation. Soc Neurosci Abstr 1993; 19: 990.
14. Han J, Chen X, Yuan Y, Yan S. Transcutaneous electrical nerve stimulation for treatment of spinal spasticity. Chin Med 11994; 107: 6-11.
15. Goulet C, Arsenault A, Bourbonnais D, Laramee MT, Lepage Y. Effects of transcutaneous electrical nerve stimulation on H-reflex and spinal spasticity. Scand lRehabil Med 1996; 28: 169-76.
16. Sonde L, Gip C, Fernaeus SE, Nilsson CG, Vlitanen M. Stimulation with low frequency (1.7 Hz) transcutaneous electric nerve stimulation (low-TENS) increases motor function of the post-stroke paretic arm. Scand I Rehabil Med 1998; 30: 95-99.
17. Wang RY, Chan RC, Tsai MW. Effects of thoracolumbar electric sensory stimulation on knee extensor spasticity of persons who survived cerebrovascular accident (CVA). J Rehabil Res Dev 2000; 37: 73-80.
18. Johansson B, Haker E, von Arbin M, Britton M, Langstom G, Terent A et at. Acupuncture and transcutaneous nerve stimulation in stroke rehabilitation. Stroke 2001; 32: 707-13.
19. Fredriksen T, Bergmann S, Hesselberg J, Stolt-Nielsen A, Ringkjøb R, Sjaastad O. Electrical stimulation in multiple sclerosis: comparison of transcutaneous electrical stimulation and epidural spinal cord stimulation. Appl Neurophysiol 1986; 49: 4-24.
20. Mattison P. Transcutaneous electrical nerve stimulation in the management of painful muscle spasm in patients with multiple sclerosis. Clin Rehabil 1993; 7: 45-48.
21. Armutlu K, Meric A, Kirdi N, Yakut E, Karabudak R. The effect of transcutaneous electrical nerve stimulation in multiple sclerosis: a pilot study. Neurorehabil Neural Repair 2003; 17: 79-82.
22. Hale JL, Chan CWY. The acute effects of conventional TENS in the management of spasticity. Physiother Can 1986; 38: S5.
23. Levin M, Chan CWY. Stretch reflex latency changes following repetitive reciprocal and hetero-segmental stimulation in spastic hemiplegic subjects. Soc Neurosci Abstr 1989; 15: 916.
24. Potisk K, Gregoric M, Vodovnik L. Effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in patients with hemiplegia. Scand J Rehabil Med 1995; 27: 169-74.
25. Daly JJ, Marsolais B, Mendell LM, Rymer WZ, Stefanovska A, Wolpaw JR et al. Therapeutic neural effects of electrical stimulation. IEEE Trans Rehabil Eng 1996; 4: 218-29.
26. Gregoric M. Suppression of flexor reflex by transcutaneous electrical nerve stimulation in spinal cord injured patients. Muscle Nerve 1998; 2: 166-72.
27. Levin MF, Chan CWY. Are H and stretch reflexes in herniparesis reproducible and correlated with spasticity? J Neurol 1993; 240: 63-71.
28. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192: 540-42.
29. Bohannon RW, Smith MB. Inter-rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
30. Nuyens G, De Weerdt W, Ketelaar P, Feys H, De Wolf I, Hanston L et al. Inter-rater reliability of the Ashworth scale in multiple sclerosis. Clin Rehabil 1994; 8: 286-92.
31. Gregson IM, Leathley M, Moore PA, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the Modified Ashworth Scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil 1999; 80: 1013-16.
32. Zajicekj, Fox P, Sanders H, Nunn A, Thompson A. Cannabinoids in multiple sclerosis (CAMS) study. Lancet 2003; 362: 1517-26.
33. Neilson JF, Sinkjaer T. A comparison of clinical and laboratory measures of spasticity. Mult Scler 1996; 1: 296-301.
34. Penn RD, Savoy SM, Corcos D, Latash M, Gottlier G, Parke B et al. Intrathecal Baclofen for severe spasticity. New Engl J Med 1989; 320: 1517-21.
35. Wang RY, Tsai MW, Chan RC. Effects of surface spinal cord stimulation on spasticity and quantitative assessment of muscle tone in hemiplegic patients. Am J Phys Med Rehabil 1998; 77: 282-87.
36. Vaksh TL. Spinal opiates: a review of their effect on spinal function with emphasis on pain processing. Acta Anaesthesiol Scand Suppl 1987; 85: 25-37.
37. Chakour M, Gibson SJ, Neufeld M, Khalil Z, Helme RD. Development of an active placebo for studies of TENS treatment. In Devor M, Rowbotharn MC, Wiesenfeld-Hallin Z eds. Ninth World Congress on pain. IASP Press, 2000: 987-92.
38. Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram PJ, Warner M et al. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). Brain 2006; 129: 224-34.